Some pharma companies with promising GLP-1 trials could do quite well next year: portfolio manager

There are opportunities in the pharma space for those who can take on a bit of risk, says Eden Rahim, portfolio manager at Next Edge Capital.

December 27, 2023 at 4:18PM EST